Communiqués Arcus Biosciences, Inc.

Actions

RCUS

US03969F1093

Recherche biotechnologique et médicale

Marché Fermé - NYSE 22:00:02 24/09/2026			Varia. 5j.	Varia. 1 janv.
25,06 ^USD	-5,04 %		-1,88 %	+5,16 %

22/09	Arcus Biosciences, Inc. annonce de nouvelles données sur le casdatifan comme traitement du cancer du rein à plusieurs lignes de traitement	CI
16/09	Arcus Biosciences, Inc. : TD Cowen maintient sa recommandation à l'achat	ZM

Communiqués

24/09	Arcus Biosciences Announces New Employment Inducement Grants	BU
22/09	Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy	BU
09/09	Arcus Biosciences Announces New Employment Inducement Grants	BU
26/08	Arcus Biosciences to Participate in Three Upcoming Investor Conferences	BU
11/08	Arcus Biosciences Announces New Employment Inducement Grants	BU
05/08	Arcus Biosciences : Reports Second-Quarter 2026 Financial Results and Provides a P...	PU
05/08	Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update	BU
27/07	Arcus Biosciences Announces New Employment Inducement Grants	BU
22/07	Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients	BU
22/07	Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer	BU
22/07	Arcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer	BU
21/07	Arcus Biosciences : to Host Conference Call to Discuss Second-Quarter 2026 Financi...	PU
21/07	Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates	BU
09/07	Arcus Biosciences Announces New Employment Inducement Grants	BU
01/07	New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan	BU
24/06	Arcus Biosciences Announces New Employment Inducement Grants	BU
09/06	Arcus Biosciences Announces New Employment Inducement Grants	BU
04/06	Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD-L1/VEGF-A Bispecific Immunomodulator to Treat Kidney Cancer	AQ
03/06	Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer	BU
26/05	Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference	BU
06/05	Arcus Biosciences : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
05/05	Arcus Biosciences : Reports First-Quarter 2026 Financial Results and Provides a Pi...	PU
05/05	Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update	BU
27/04	Arcus Biosciences Announces New Employment Inducement Grants	AQ
24/04	Arcus Biosciences Announces New Employment Inducement Grants	BU